Cardiovascular Systems price target raised to $21 from $15 at JMP Securities

theflyonthewall.com

JMP Securities raised its target on Cardiovascular Systems after the company reported higher than expected Q2 revenue. The firm believes that the stock is undervalued and it reiterates an Outperform rating.

Rates

View Comments (0)